Home/Filings/4/0001418812-19-000025

4//SEC Filing

Hale David Robert 4

Accession 0001418812-19-000025

CIK 0000885590other

View on SEC.gov Company Profile

Filed

May 2, 8:00 PM ET

Accepted

May 3, 5:46 PM ET

Size

26.8 KB

Accession

0001418812-19-000025

Insider Transaction Report

Form 4

Period: 2019-05-01

Bausch Health Companies Inc.BHC

ValueAct Capital Master Fund, L.P.

DirectorOther

Transactions

Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total
Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

ValueAct Capital Management, LLC

DirectorOther

Transactions

Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total
Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

ValueAct Holdings II, L.P.

DirectorOther

Transactions

Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total
Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

Hale David Robert

DirectorOther

Transactions

Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total
Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

ValueAct Capital Management, L.P.

DirectorOther

Transactions

Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total
Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
1,059,793
Common Stock, no par value
(indirect: See Footnotes)
16,973,356

ValueAct Holdings GP, LLC

DirectorOther

Transactions

Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total
Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

ValueAct Holdings, L.P.

DirectorOther

Transactions

Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total
Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

ValueAct Co-Invest Master Fund, L.P.

DirectorOther

Transactions

Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total
Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

VA Partners I, LLC

DirectorOther

Transactions

Award
Common Stock, no par value
2019-05-03$23.51/sh+10,633$249,982→ 20,518 total
Tax Payment
Common Stock, no par value
2019-05-01$23.63/sh−3,996$94,425→ 9,885 total

Holdings

Common Stock, no par value
(indirect: See Footnotes)
16,973,356
Common Stock, no par value
(indirect: See Footnotes)
1,059,793

Footnotes (6)

[F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
[F2]All board compensation accrues to the benefit of the investors in ValueAct Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, D. Robert Hale is deemed to hold the restricted share units for the benefit of the limited partners of ValueAct Capital Master Fund, L.P. and indirectly for (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P.
[F3]Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
[F4]Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health(the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health.
[F5]The securities reported herein are held by ValueAct Capital Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P.
[F6]The securities reported herein are directly beneficially owned by ValueAct Co-Invest Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Co-Invest Master Fund, L.P. , (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Co-Invest Master Fund, L.P. , (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Bausch Health Companies Inc.

CIK 0000885590

→

Entity typeother

Related Parties

filerCIK 0001635643

Filing Metadata

Form type: 4
Filed: May 2, 8:00 PM ET
Accepted: May 3, 5:46 PM ET
Size: 26.8 KB

View on SEC.gov